Monthly Formulary Amendments – July 2023

Monthly Formulary Amendments Documents list any NICE Technology Appraisals, NICE Guidelines, MHRA Drug Safety Updates, and National Patient Safety Alerts published in the previous calendar month which may have an impact on local formularies and guidelines.  This document is for APCs, and formulary committees to ensure formularies remain up to date, and in line with latest NICE guidance and safety information.

This edition covers guidance and alerts published in July 2023.

It includes a suggested formulary position for APCs/formulary committees, together with a summary of any financial/commissioning implications. The purpose of the document is to support consistent decision making by APCs.

This information is produced for use by NHS healthcare professionals and RDTC stakeholders.

Prescribing Update Newsletter – July 2023

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

This month’s edition focuses on the budget impact of methylphenidate modified release tablet choice, the effect of price concessions on prescribing budgets, and changes to the shingles vaccination programme. It also includes another in the series of “Meet the Team” where you can get to know the people behind the work we do. There is also information on serious shortage protocols, some key medicines availability, new and updated NICE guidance, and UK product launches.

View the preview below on desktop, or click here to download a copy.

Effect of social prescribing on medicines use in primary care – GNPRC 2023

This poster was first presented at the Great North Pharmacy Research Collaborative in July 2023. It investigates the impact of social prescribing on primary care prescribing of medicines in practices with a high level of deprivation; find the poster and abstract below.

Download the poster here.

Impact of deprivation on primary care prescribing by AWARE category – GNPRC 2023

This poster was first presented at the Great North Pharmacy Research Collaborative in July 2023. It investigates the impact of deprivation on antimicrobial prescribing; find the poster and abstract below.

Download the poster here.

Population demographics of patients prescribed opiates in the North of England ICSs – GNPRC 2023

This poster was presented at the Great North Pharmacy Research Collaborative in July 2023 in Newcastle. It was previously presented at Feeling the Pain: Reducing Harm Caused by Opioids for Non-Cancer Pain, in November 2022. It aims to support greater understanding of the patient populations prescribed opioids, the demographics and the inter-relationships and dependencies between prescribing; find the poster and abstract below.

Download the poster here.

Opioid overprescribing and sustainability considerations in the North of England – GNPRC 2023

This poster was first presented at the Great North Pharmacy Research Collaborative in July 2023. It tests a simple model to estimate the carbon footprint and cost impact of reducing opioid overprescribing in the most deprived deciles; find the poster and abstract below.

Download the poster here.

Access to opioids in Urgent and Emergency Care settings in NENC ICS – GNPRC 2023

This poster was first presented at the Great North Pharmacy Research Collaborative in July 2023. It investigates access to opioids in UEC settings to identify trends, variations, and areas of good practice; find the poster and abstract below.

Download the poster here.

Monthly Horizon Scanning Report – July 2023

Monthly horizon scanning reports are designed to inform the NHS about new products, significant changes to product licenses, significant new guidance, and decisions that have been made by recognised bodies. 

This information is produced for use by NHS healthcare professionals. 

Monthly Formulary Amendments – July 2022

Monthly Formulary Amendments Documents list any NICE Technology Appraisals, NICE Guidelines, RMOC Guidance, MHRA Drug Safety Updates, and National Patient Safety Alerts published in the previous calendar month which may have an impact on local formularies and guidelines.  This document is for APCs, and formulary committees to ensure formularies remain up to date, and in line with latest NICE guidance and safety information.

This edition covers guidance and alerts published in July 2022.

It includes a suggested formulary position for APCs/formulary committees, together with a summary of any financial/commissioning implications. The purpose of the document is to support consistent decision making by APCs.

This information is produced for use by NHS healthcare professionals and RDTC stakeholders.

Problematic polypharmacy: prescribing cascades evidence evaluation – GNPRC 2022

This poster was first presented at the Great North Pharmacy Research Collaborative in July 2022.

The identification and reversal of prescribing cascades represents an important and underappreciated opportunity to reduce inappropriate medication use and preventable ADRs, and to make prescribing more environmentally sustainable The overall purpose of this evidence evaluation is to raise awareness of potential prescribing cascades and to highlight strategies, tools, and resources to help identify, prevent, and resolve them.

Download the poster here.

An abstract is also available.